10x Genomics, Inc. — Director's Dealing 2020

Jun 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-06-15

Reporting Person: SULIMAN SHEHNAAZ (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-15	Stock Option (right to buy)	$88.42	A	4432	Acquired	2030-06-15	Class A Common Stock (4432)	Direct

Footnotes

F1: This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2020 and each month thereafter, subject to the reporting person continuing as a service provider through each such date.